137 related articles for article (PubMed ID: 37506477)
1. Evaluation of breast cancer malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model.
Chang H; Wang D; Li Y; Xiang S; Yang YX; Kong P; Fang C; Ming L; Wang X; Zhang C; Jia W; Yan Q; Liu X; Zeng Q
Eur J Radiol; 2023 Sep; 166():111003. PubMed ID: 37506477
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a continuous-time random-walk diffusion model for the differentiation of malignant and benign breast lesions and its association with Ki-67 expression.
Du M; Zou D; Gao P; Yang Z; Hou Y; Zheng L; Zhang N; Liu Y
NMR Biomed; 2023 Aug; 36(8):e4920. PubMed ID: 36912198
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Prognostic Factors and Molecular Subtypes of Breast Cancer With a Continuous-Time Random-Walk MR Diffusion Model: Using Whole Tumor Histogram Analysis.
Qin Y; Tang C; Hu Q; Yi J; Yin T; Ai T
J Magn Reson Imaging; 2023 Jul; 58(1):93-105. PubMed ID: 36251468
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer diagnosis and prognosis using a high b-value non-Gaussian continuous-time random-walk model.
Feng H; Liu H; Wang Q; Song M; Yang T; Zheng L; Wu D; Shao X; Shi G
Clin Radiol; 2023 Sep; 78(9):e660-e667. PubMed ID: 37344324
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Assessment of Restriction Spectrum MR Imaging for the Diagnosis of Breast Cancer and Association With Prognostic Factors.
Qin Y; Tang C; Hu Q; Zhang Y; Yi J; Dai Y; Ai T
J Magn Reson Imaging; 2023 Jun; 57(6):1832-1841. PubMed ID: 36205354
[TBL] [Abstract][Full Text] [Related]
7. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
[TBL] [Abstract][Full Text] [Related]
8. Comparison of continuous-time random walk and fractional order calculus models in characterizing breast lesions using histogram analysis.
Tang C; Li F; He L; Hu Q; Qin Y; Yan X; Ai T
Magn Reson Imaging; 2024 May; 108():47-58. PubMed ID: 38307375
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric diffusion-weighted imaging in breast lesions: Association with pathologic diagnosis and prognostic factors.
Suo S; Cheng F; Cao M; Kang J; Wang M; Hua J; Hua X; Li L; Lu Q; Liu J; Xu J
J Magn Reson Imaging; 2017 Sep; 46(3):740-750. PubMed ID: 28139036
[TBL] [Abstract][Full Text] [Related]
10. Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions.
Iima M; Kataoka M; Kanao S; Onishi N; Kawai M; Ohashi A; Sakaguchi R; Toi M; Togashi K
Radiology; 2018 May; 287(2):432-441. PubMed ID: 29095673
[TBL] [Abstract][Full Text] [Related]
11. Diffusion kurtosis imaging does not improve differentiation performance of breast lesions in a short clinical protocol.
Palm T; Wenkel E; Ohlmeyer S; Janka R; Uder M; Weiland E; Bickelhaupt S; Ladd ME; Zaitsev M; Hensel B; Laun FB
Magn Reson Imaging; 2019 Nov; 63():205-216. PubMed ID: 31425816
[TBL] [Abstract][Full Text] [Related]
12. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
Liu C; Liang C; Liu Z; Zhang S; Huang B
Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
[TBL] [Abstract][Full Text] [Related]
13. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
14. Differentiating low- and high-grade pediatric brain tumors using a continuous-time random-walk diffusion model at high b-values.
Karaman MM; Sui Y; Wang H; Magin RL; Li Y; Zhou XJ
Magn Reson Med; 2016 Oct; 76(4):1149-57. PubMed ID: 26519663
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of benign and malignant breast lesions using diffusion-weighted imaging with a fractional-order calculus model.
Wang C; Wang G; Zhang Y; Dai Y; Yang D; Wang C; Li J
Eur J Radiol; 2023 Feb; 159():110646. PubMed ID: 36577184
[TBL] [Abstract][Full Text] [Related]
16. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
[TBL] [Abstract][Full Text] [Related]
17. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma.
Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R
J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239
[TBL] [Abstract][Full Text] [Related]
18. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient.
Suo S; Zhang K; Cao M; Suo X; Hua J; Geng X; Chen J; Zhuang Z; Ji X; Lu Q; Wang H; Xu J
J Magn Reson Imaging; 2016 Apr; 43(4):894-902. PubMed ID: 26343918
[TBL] [Abstract][Full Text] [Related]
19. Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.
Li X; Fan Z; Jiang H; Niu J; Bian W; Wang C; Wang Y; Zhang R; Zhang H
Sci Rep; 2023 Oct; 13(1):17978. PubMed ID: 37864025
[TBL] [Abstract][Full Text] [Related]
20. Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer.
Durando M; Gennaro L; Cho GY; Giri DD; Gnanasigamani MM; Patil S; Sutton EJ; Deasy JO; Morris EA; Thakur SB
Eur J Radiol; 2016 Sep; 85(9):1651-8. PubMed ID: 27501902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
